Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

IV-X Medical First-in-Human Peripheral Intravascular Lithotripsy Study for PAD

NCT: NCT07747883 · NOT_YET_RECRUITING

NCT IDNCT07747883
StatusNOT_YET_RECRUITING
Start Date2026-09-14
Completion2026-11-30
SponsorIVX Medical (INDUSTRY)
First posted
Last updated

Brief Summary

To evaluate the safety and performance of the IV-X Medical Intravascular Lithotripsy (IVL) System in adults in order to demonstrate the ability of the IV-X Medical IVL System to safely and effectively deliver IVL treatment calcified peripheral arteries (iliac, femoral, ilio-femoral, popliteal, and infra-popliteal arteries).

Frequently Asked Questions

What is IV-X Medical First-in-Human Peripheral Intravascular Lithotripsy Study for PAD?

IV-X Medical First-in-Human Peripheral Intravascular Lithotripsy Study for PAD is a clinical trial registered under NCT07747883. Current status: NOT_YET_RECRUITING.

What is the status of NCT07747883?

The current status of NCT07747883 (IV-X Medical First-in-Human Peripheral Intravascular Lithotripsy Study for PAD) is: NOT_YET_RECRUITING.

When did IV-X Medical First-in-Human Peripheral Intravascular Lithotripsy Study for PAD start?

IV-X Medical First-in-Human Peripheral Intravascular Lithotripsy Study for PAD started on 2026-09-14.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑